- Home
- OCFT vs NVCT Comparison
OCFT vs NVCT Comparison
Compare OCFT & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFT
- NVCT
- Stock Information
- Founded
- OCFT 2015
- NVCT 2020
- Country
- OCFT China
- NVCT United States
- Employees
- OCFT N/A
- NVCT N/A
- Industry
- OCFT Computer Software: Programming Data Processing
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- OCFT Technology
- NVCT Health Care
- Exchange
- OCFT Nasdaq
- NVCT Nasdaq
- Market Cap
- OCFT 236.7M
- NVCT 249.1M
- IPO Year
- OCFT 2019
- NVCT 2022
- Fundamental
- Price
- OCFT $7.10
- NVCT $9.37
- Analyst Decision
- OCFT
- NVCT Strong Buy
- Analyst Count
- OCFT 0
- NVCT 3
- Target Price
- OCFT N/A
- NVCT $17.00
- AVG Volume (30 Days)
- OCFT 74.7K
- NVCT 132.1K
- Earning Date
- OCFT 05-28-2025
- NVCT 05-06-2025
- Dividend Yield
- OCFT N/A
- NVCT N/A
- EPS Growth
- OCFT N/A
- NVCT N/A
- EPS
- OCFT N/A
- NVCT N/A
- Revenue
- OCFT $260,815,958.00
- NVCT N/A
- Revenue This Year
- OCFT N/A
- NVCT N/A
- Revenue Next Year
- OCFT $6.37
- NVCT N/A
- P/E Ratio
- OCFT N/A
- NVCT N/A
- Revenue Growth
- OCFT N/A
- NVCT N/A
- 52 Week Low
- OCFT $0.87
- NVCT $4.44
- 52 Week High
- OCFT $7.38
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- OCFT 68.12
- NVCT 49.95
- Support Level
- OCFT $7.05
- NVCT $9.15
- Resistance Level
- OCFT $7.28
- NVCT $11.15
- Average True Range (ATR)
- OCFT 0.19
- NVCT 0.60
- MACD
- OCFT 0.01
- NVCT -0.06
- Stochastic Oscillator
- OCFT 76.60
- NVCT 45.12
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a technology-as-a-service provider for the financial services industry. It integrates extensive expertise in the industry with market technology to provide technology applications and technology-enabled business services to financial institutions. The integrated solutions and platforms it provides include digital banking solutions, digital insurance solutions, and the Gamma Platform, a technology infrastructure platform for financial institutions. Geographically, the company generates substantially all of its revenue from its business in the People's Republic of China (PRC).
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.